Respir Med Case Rep . Successful recovery from COVID-19 pneumonia after receiving baricitinib, tocilizumab, and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis

[tetano]

Respir Med Case Rep


. 2020 Jun 27;31:101115.
doi: 10.1016/j.rmcr.2020.101115. eCollection 2020.
Successful recovery from COVID-19 pneumonia after receiving baricitinib, tocilizumab, and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis


Pietro Sodani ^{1 2} , Luciano Mucci ¹ , Rita Girolimetti ¹ , Silvia Tedesco ¹ , Francesca Monaco ¹ , Daniele Campanozzi ¹ , Marino Brunori ¹ , Stefania Maltoni ¹ , Samuele Bedetta ¹ , Anna M Di Carlo ¹ , Piero Candoli ³ , Mauro Mancini ⁴ , Alberto Rebonato ⁵ , Francesca D'Adamo ⁶ , Maria Capalbo ⁷ , Gabriele Frausini ¹



Affiliations

• PMID: 32670785
• PMCID: PMC7320265
• DOI: 10.1016/j.rmcr.2020.101115

Abstract

The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic, threatening global public health. In the current paper, we describe our successful treatment of one COVID-19 pneumonia patient case with high mortality risk factors. Our experience underlines the importance of the use of a multidisciplinary therapeutic approach in order to achieve a favorable clinical outcome. Further, enhancing the capability of the COVID-19 diagnosis with the use of the chest imaging modalities is discussed.

Keywords: COVID-19; Coronavirus; SARS-CoV-2; Viral pneumonia.